Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
$22.96 - $85.21
Next Earnings Date
May 15 2025
Next Earnings Date
May 15 2025
Latest price
Market Cap | $10.17B |
EV | $9.34B |
Shares Outstanding | 201.06M |
Beta | 1.41 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | $71.82 |
P/E 2025E | 41.39x |
P/Revenue 2025E | 17.86x |
Revenue | 32.00% |
EPS | 60.50% |
Operating Cash Flow | 30.40% |
Free Cash Flow | 40.80% |
Revenue | 14.60% |
EPS | 19.50% |
Operating Cash Flow | 21.30% |
Free Cash Flow | 21.40% |
Gross Margin 2025E | 92.03% |
Net Profit Margin 2025E | 35.17% |
ROE 2025E | 26.18% |
ROCE 2024 | 15.81% |
DPS 2025E | $0.00 |
Payout Ratio 2025E | 0.00% |
Div. Yield 2025E | 0.00% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Doximity, Inc.
DOCS
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Tangney, Jeffrey
Employees
827
Website
www.doximity.comIPO Date
2021-06-24
Headquarters
500 3rd Street, Suite 510, San Francisco, California, 94107, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved